Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature

Simple item page
dc.contributor.authorGuarda, Francisco J.
dc.contributor.authorGong, W.
dc.contributor.authorGhajar, A.
dc.contributor.authorGuitelman, M.
dc.contributor.authorNachtigall, L. B.
dc.date.accessioned2022-11-09T15:04:47Z
dc.date.available2022-11-09T15:04:47Z
dc.date.issued2020
dc.fuente.origenSpringer
dc.identifier.doi10.1007/s11102-020-01050-2
dc.identifier.eissn1573-7403
dc.identifier.issn1386-341X
dc.identifier.urihttps://doi.org/10.1007/s11102-020-01050-2
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/65396
dc.information.autorucEscuela de medicina ; Guarda, Francisco J. ; S/I ; 149942
dc.language.isoen
dc.nota.accesoContenido parcial
dc.revistaPituitary
dc.rightsacceso restringido
dc.subjectAcromegaly
dc.subjectPegvisomant
dc.subjectPregnancy
dc.subjectPituitary
dc.subjectGrowth hormone
dc.subjectIGF-1
dc.titlePreconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literaturees_ES
dc.typeartículo
sipa.codpersvinculados149942
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Preconception use of pegvisomant alone or as combination therapy for acromegaly - a case series and review of the literature.pdf
Size:
3.07 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas